These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7972088)

  • 1. The peptide p2Ca is immunodominant in allorecognition of Ld by beta chain variable region V beta 8+ but not V beta 8- strains.
    Connolly JM
    Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11482-6. PubMed ID: 7972088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence restrictions in T cell receptor beta-chains that have specificity for a self-peptide/Ld complex.
    Tjoa BA; Kranz DM
    Mol Immunol; 1994 Jul; 31(10):705-11. PubMed ID: 7518567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naturally occurring low affinity peptide/MHC class I ligands can mediate negative selection and T cell activation.
    Motyka B; Teh HS
    J Immunol; 1998 Jan; 160(1):77-86. PubMed ID: 9551958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biased T cell receptor usage by Ld-restricted, tum- peptide-specific cytotoxic T lymphocyte clones.
    Solheim JC; Alexander-Miller MA; Martinko JM; Connolly JM
    J Immunol; 1993 Feb; 150(3):800-11. PubMed ID: 8380825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide length variants p2Ca and QL9 present distinct conformations to L(d)-specific T cells.
    Hornell TM; Martin SM; Myers NB; Connolly JM
    J Immunol; 2001 Oct; 167(8):4207-14. PubMed ID: 11591741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alloreactive cytotoxic T lymphocytes generated in the presence of viral-derived peptides show exquisite peptide and MHC specificity.
    Alexander-Miller MA; Burke K; Koszinowski UH; Hansen TH; Connolly JM
    J Immunol; 1993 Jul; 151(1):1-10. PubMed ID: 8392095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential V beta usage by cytotoxic T cells cross-reactive between two epitopes of HIV-1 gp160 and degenerate in class I MHC restriction.
    Shirai M; Vacchio MS; Hodes RJ; Berzofsky JA
    J Immunol; 1993 Aug; 151(4):2283-95. PubMed ID: 7688397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homology between an alloantigen and a self MHC allele calibrates the avidity of the alloreactive T cell repertoire independent of TCR affinity.
    Hornell TM; Myers N; Hansen TH; Connolly JM
    J Immunol; 2003 May; 170(9):4506-14. PubMed ID: 12707327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of cytotoxic T-lymphocytes to a self-peptide/class I complex: a model for peptide-mediated tumor rejection.
    Tjoa BA; Kranz DM
    Cancer Res; 1994 Jan; 54(1):204-8. PubMed ID: 7505197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of allorecognition by an H-2Kb-derived peptide is evidence for a T-cell binding region on a major histocompatibility complex molecule.
    Schneck J; Munitz T; Coligan JE; Maloy WL; Margulies DH; Singer A
    Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8516-20. PubMed ID: 2813409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cytotoxic T lymphocyte clone can recognize the same naturally occurring self peptide in association with a self and nonself class I MHC protein.
    Dutz JP; Tsomides TJ; Kageyama S; Rasmussen MH; Eisen HN
    Mol Immunol; 1994 Sep; 31(13):967-75. PubMed ID: 8084337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis of 2C TCR allorecognition of H-2Ld peptide complexes.
    Speir JA; Garcia KC; Brunmark A; Degano M; Peterson PA; Teyton L; Wilson IA
    Immunity; 1998 May; 8(5):553-62. PubMed ID: 9620676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination with T cell receptor peptides primes anti-receptor cytotoxic T lymphocytes (CTL) and anergizes T cells specifically recognized by these CTL.
    Kuhröber A; Schirmbeck R; Reimann J
    Eur J Immunol; 1994 May; 24(5):1172-80. PubMed ID: 7514132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules.
    Shirai M; Pendleton CD; Berzofsky JA
    J Immunol; 1992 Mar; 148(6):1657-67. PubMed ID: 1371784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloreactive and syngeneic CTL are comparably dependent on interaction with MHC class I alpha-helical residues.
    Hornell TM; Solheim JC; Myers NB; Gillanders WE; Balendiran GK; Hansen TH; Connolly JM
    J Immunol; 1999 Sep; 163(6):3217-25. PubMed ID: 10477590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of T cell receptors specific for recognition of class IB antigens.
    Lowen LC; Aldrich CJ; Forman J
    J Immunol; 1993 Dec; 151(11):6155-65. PubMed ID: 8245458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific prolongation of allograft survival by a T-cell-receptor-derived peptide.
    Goss JA; Alexander-Miller MA; Gorka J; Flye MW; Connolly JM; Hansen TH
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):9872-6. PubMed ID: 8234328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A self-reactive class I-restricted T-cell response of H-2b mice to determinants of the V beta 8.2 domain of the T-cell receptor for antigen.
    Kuhröber A; Schirmbeck R; Reimann J
    Immunology; 1994 Dec; 83(4):532-9. PubMed ID: 7533132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allospecific cytotoxic T lymphocytes recognize an H-2 peptide in the context of a murine major histocompatibility complex class I molecule.
    Song ES; Linsk R; Olson CA; McMillan M; Goodenow RS
    Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1927-31. PubMed ID: 3258067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H-2Ld-alloreactive T cell hybridomas utilize diverse V alpha and V beta T cell receptor chains.
    Louie KA; Ochoa-Garay J; Chen PJ; McKinney D; Groshen S; McMillan M
    Mol Immunol; 1996 Jun; 33(9):747-58. PubMed ID: 8811070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.